Mannatech (NASDAQ:MTEX) was downgraded by analysts at ValuEngine from a “hold” rating to a “sell” rating in a research report issued to clients and investors on Friday.
Shares of Mannatech (NASDAQ MTEX) remained flat at $$14.45 during mid-day trading on Friday. 8,197 shares of the company were exchanged, compared to its average volume of 4,417. Mannatech has a 1-year low of $12.51 and a 1-year high of $19.80. The firm has a market capitalization of $39.27, a PE ratio of 72.25 and a beta of 1.03. The company has a quick ratio of 1.33, a current ratio of 1.63 and a debt-to-equity ratio of 0.01.
Mannatech (NASDAQ:MTEX) last announced its earnings results on Tuesday, November 7th. The company reported $0.50 EPS for the quarter. Mannatech had a net margin of 3.29% and a return on equity of 13.43%. The business had revenue of $42.00 million during the quarter.
An institutional investor recently bought a new position in Mannatech stock. Northern Trust Corp bought a new position in shares of Mannatech, Inc. (NASDAQ:MTEX) in the second quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor bought 10,168 shares of the company’s stock, valued at approximately $158,000. Northern Trust Corp owned about 0.38% of Mannatech as of its most recent filing with the Securities and Exchange Commission (SEC). Institutional investors and hedge funds own 18.89% of the company’s stock.
Mannatech Company Profile
Mannatech, Incorporated is a wellness solution provider. The Company develops and sells nutritional supplements, topical and skin care and anti-aging products, and weight-management products. The Company operates through the segment of sale of nutritional supplements, skin care and anti-aging products, and weight management and fitness products through network marketing distribution channels in approximately 20 countries.
To view ValuEngine’s full report, visit ValuEngine’s official website.
Receive News & Ratings for Mannatech Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Mannatech and related companies with MarketBeat.com's FREE daily email newsletter.